For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231027:nRSa6018Ra&default-theme=true
RNS Number : 6018R R&Q Insurance Holdings Ltd 27 October 2023
R&Q Insurance Holdings Ltd
("R&Q" or the "Company")
PDMR/Director Shareholding and Total Voting Rights
27 October 2023
R&Q Insurance Holdings Ltd (AIM: RQIH) ("R&Q" or the "Group"), the
leading non-life global specialty insurance company focusing on the Program
Management ("Accredited") and Legacy Insurance ("R&Q Legacy") businesses,
announces that on 23 October 2023, Andrew Pinkes, a PDMR, to fund tax
liabilities arising from the vesting of his share award, sold 218,220 Ordinary
Shares, which in accordance with his share award agreement, have been
purchased by the Company to be held in Treasury.
PDMR Dealing
Name of Director Total Restricted Ordinary Shares Vested Total Ordinary Shares Sold Total Ordinary Shares Retained Total R&Q Ordinary Shares now held % of voting rights
Andrew Pinkes 490,597 218,220 272,377 517,675 0.14%
Total Voting Rights
As a result of this transaction the total issued share capital will remain
377,395,235 Ordinary Shares. Of which 3,790,917 Ordinary Shares are now held
in Treasury. Therefore, the total number of voting rights will be 373,604,318
and may be used by Shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries to:
R&Q Insurance Holdings Ltd
William Spiegel Tel: 0207 780 5850
Tom Solomon Tel: 0207 780 5850
Numis Securities Limited (Nominated Advisor and Joint Broker)
Giles Rolls Tel: 020 7260 1000
Charles Farquhar Tel: 020 7260 1000
Barclays Bank PLC (Joint Broker)
Andrew Tusa Tel: 020 7632 2322
FTI Consulting
Tom Blackwell Tel: 020 3727 1051
Notes to Editors:
About R&Q
R&Q is a global non-life specialty insurance company. We operate two core,
highly complementary, businesses: Program Management and Legacy Insurance.
Both these businesses are leaders in their respective markets.
Our approach is to deploy our origination and underwriting capabilities,
alongside our licensed and rated carriers in the US, EU and the UK, to
generate attractive fee returns in Program Management and Legacy Insurance.
Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94
Website: www.rqih.com (http://www.rqih.com)
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibility / person closely
associated
a) Name Andrew Pinkes
2 Reason for the notification
a) Position/status PDMR (Senior Executive)
b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name R&Q Insurance Holdings Ltd
b) LEI 2138006K1U38QCGLFC94
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 2 pence each of the Company
Identification code Ordinary share ISIN: BMG7371X1065
Sale of 218,220 Ordinary Shares
b) Nature of transaction
c) Price(s) and volume(s) Price(s) Volume(s)
1. Par value of 2p at Grant Par value of 2p: £4,308.9
2 £0.24 Sale of 218,220 shares for a total consideration of £ 52,372.80
d) Aggregated information
As above
Aggregated volume
Price As above
e) Date of transaction 23 October 2023
f) Place of transaction Outside of trading location
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEASEXALNDFFA